Skip to main content
Year archive

Biotest AG — 2010 filings

All 64 regulatory filings released by Biotest AG (BIO3) in 2010, sourced directly from the official regulator.

64 Filings
2010 Period
2010 filings (64)
Filing Released Lang
Biotest AG: Clinical and pre-clinical data emphasise the potential of
Regulatory Filings
2010-12-06 English
Biotest AG: Biotest: Pre-clinical studies demonstrate high efficacy of BT-062 in solid tumours
Regulatory Filings
2010-11-17 English
Biotest AG: Biotest experiences sales growth
Earnings Release 9M 2010
2010-11-08 English
Investor Presentation 2010
Investor Presentation
2010-11-08 German
Investor Presentation 2010
Investor Presentation
2010-11-08 English
Q3 Report 2010
Interim / Quarterly Report 9M 2010
2010-11-08 German
Biotest AG: Biotest submits BivigamTM dossier for regulatory approval to US Food and Drug Administration
Regulatory Filings
2010-11-03 English
Biotest AG: Monoclonal antibody BT-061 shows potential in the indication multiple sclerosis
Regulatory Filings
2010-10-21 English
Investor Presentation 2010
Investor Presentation
2010-09-22 German
Investor Presentation 2010
Investor Presentation
2010-09-22 English
Investor Presentation 2010
Investor Presentation
2010-09-08 German
Investor Presentation 2010
Investor Presentation
2010-09-08 English
DGAP-DD: Biotest AG english
Director's Dealing
2010-08-25 English
Investor Presentation 2010
Investor Presentation
2010-08-24 German
Investor Presentation 2010
Investor Presentation
2010-08-24 English
Investor Presentation 2010
Investor Presentation
2010-08-23 English
Investor Presentation 2010
Investor Presentation
2010-08-23 German
Investor Presentation 2010
Investor Presentation
2010-08-19 English
Biotest AG: Positive perspective despite difficult environment
Earnings Release H1 2010
2010-08-12 English
Q2 Report 2010
Interim / Quarterly Report H1 2010
2010-08-12 German
Biotest AG: Development of BT-062 makes further progress with start of a new clinical trial
Legal Proceedings Report
2010-08-11 English
Biotest AG: Immunomodulatory antibody BT-061 shows competitive efficacy in the indication Rheumatoid Arthritis
Regulatory Filings
2010-08-10 English
DGAP-DD: Biotest AG english
Director's Dealing
2010-07-16 English
DGAP-DD: Biotest AG english
Director's Dealing
2010-07-15 English
DGAP-DD: Biotest AG english
Director's Dealing
2010-07-15 English
Biotest AG: Biotest increases sales despite greater financial pressure
Earnings Release H1 2010
2010-07-14 English
Biotest AG: Preliminary Results
Earnings Release H1 2010
2010-07-14 English
Interim / Quarterly Report 2010
Interim / Quarterly Report H2 2010
2010-07-14 English
Interim / Quarterly Report 2010
Interim / Quarterly Report H2 2010
2010-07-14 German
Investor Presentation 2010
Investor Presentation
2010-05-31 German
Investor Presentation 2010
Investor Presentation
2010-05-31 English
Biotest AG: Biotest shows sales growth in first quarter 2010 despite a difficult environment
Earnings Release Q1 2010
2010-05-11 English
Investor Presentation 2010
Investor Presentation Q1 2010
2010-05-11 German
Investor Presentation 2010
Investor Presentation Q1 2010
2010-05-11 English
Q1 Report 2010
Interim / Quarterly Report Q1 2010
2010-05-11 German
DGAP-DD: Biotest AG english
Director's Dealing
2010-05-10 English
AGM Information 2010
AGM Information
2010-05-07 English
Call Transcript 2010
Call Transcript
2010-05-07 German
Presentation for the Annual Shareholders Meeting 2010
AGM Information
2010-05-07 English
Präsentation zur Hauptversammlung 2010
AGM Information
2010-05-07 German
Biotest AG: Annual General Meeting 2010: Shareholders Approve Dividend of EUR 0.34 per Ordinary Share and EUR 0.40 per Preference Share
AGM Information
2010-05-06 English
Biotest AG: Biotest has recorded sales growth in first quarter 2010 despite a difficult environment
Earnings Release Q1 2010
2010-05-06 English
Declaration of Voting Results & Voting Rights Announcements 2010
Declaration of Voting Results & Voting Rights Announcements
2010-04-23 German
Investor Presentation 2010
Investor Presentation
2010-04-23 German
Investor Presentation 2010
Investor Presentation
2010-04-23 English
Datum:16.04.2010
Annual Report FY 2009
2010-04-16 German
Datum:14.04.2010
Annual Report FY 2009
2010-04-14 German
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 06.05.2010 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2010-03-25 German
Report Publication Announcement 2010
Report Publication Announcement
2010-03-22 English
DGAP-DD: Biotest AG english
Director's Dealing
2010-03-22 English
Hinweis auf Halbjahresfinanzbericht
Report Publication Announcement
2010-03-22 German
Datum:22.03.2010
Report Publication Announcement
2010-03-22 German
Biotest AG: 2009 brings additional growth
Earnings Release FY 2009
2010-03-19 English
Investor Presentation 2010
Investor Presentation
2010-03-19 German
Investor Presentation 2010
Investor Presentation
2010-03-19 English
Analystenkonferenz 19.03.2010
Investor Presentation
2010-03-19 English
Annual Report 2009
Annual Report FY 2009
2010-03-19 German
Declaration of Voting Results & Voting Rights Announcements 2010
Declaration of Voting Results & Voting Rights Announcements
2010-03-17 German
Biotest AG: Monoclonal antibody BT-061 shows efficacy in the indication psoriasis
Regulatory Filings
2010-03-17 English
Biotest AG: Biotest significantly increases sales, EBIT above the high level of last year
Earnings Release FY 2009
2010-02-16 English
Report Publication Announcement 2010
Report Publication Announcement
2010-02-04 English
Hinweis auf Halbjahresfinanzbericht
Report Publication Announcement
2010-02-04 German
Datum:04.02.2010
Report Publication Announcement
2010-02-04 German
Biotest AG: Sale of Medical Diagnostics business to Bio-Rad completed
M&A Activity
2010-01-06 English